Global Investigative Journalism Network (https://archive.gijn.org/tag/covid-19/page/17/)
Чем двукратная обладательница Пулицеровской премии Марта Мендоза пользуется для изучения цепочек поставок лекарств и оборудования для борьбы с COVID-19.
In this year’s GIJN’s Editor’s Pick series, Bangla editor Miraj Chowdhury writes that, despite many free speech and coronavirus-related challenges, there are numerous examples of important journalistic investigations taking place in the region. Here are some of the stories that mattered the most in 2020 for the 215 million Bangla speakers around the world.
В Топ-10 дата-журналистики года New York Times, Financial Times, Süddeutsche Zeitung and Mediapart освещают различные аспекты кризиса COVID-19, Al Jazeera поясняет причины и возможные последствия международных конфликтов, дата-дизайнерка Федерика Фрагапане анализирует сны разных народов, а журналистка Datawrapper Лиза Шарлотта Рост презентует руководство по визуализации данных для дальтоников.
Despite government restrictions, journalists around the world are using freedom of information laws to understand the COVID-19 pandemic and the response of international, national, and local authorities. GIJN’s Toby McIntosh outlines how to craft an effective freedom of information request and provides tips and suggestions on where to make requests and important questions to ask.
At least 462 journalists have died from COVID-19, from 56 countries — with Latin American countries accounting for more than half this grim tally and a recent surge striking India and Bangladesh. One NGO tracking these deaths told GIJN that most journalists who died in the pandemic since October 1 were under the age of 60.
Para el 15 de noviembre, tenemos ya 462 periodistas fallecidos por COVID-19, en un registro de 56 países.
For this week’s Friday 5, where GIJN rounds up journalism news in English from around the world, we’re reading about the new Corruption Tracker for the international arms trade, dodgy deals in personal protective equipment procurement, and a recently launched organization to support whistleblowers legally, as well as financially.
As the United Kingdom begins its rollout of the first COVID-19 vaccine this week, the world is watching with bated breath. Our NodeXL #ddj mapping from November 30 to December 6 found Bloomberg tracking the development of nine of the most promising vaccines around the world, The New York Times creating an interactive for Americans to establish where they are in the line before they can get vaccinated, and Spain’s El Pais examining the advantages of using antigen testing for COVID-19 infections. Meanwhile, ITV News’ Stephen Hull did a fun data analysis of the assorted chocolates in a Quality Street tin.
Девять многообещающих вакцин на диаграмме Bloomberg, преимущества тестов на антитела к COVID-19 – в El Pais, и право на скрейпинг с Markup.
People around the world believe the several promising COVID-19 vaccines were designed to do the two things we most want them to do: reduce severe illness and death, and reduce the spread of the disease. But a central problem, experts say, is that none of the new vaccine trials were designed to achieve either of those goals.